Why Most Cannabis Activists Don’t Support Rescheduling

Guest Opinion by H Marty Schelper

Put on your thinking caps.

Why reschedule Cannabis merely to allow for “medical research,” when descheduling would allow equal or greater research—without government or pharmaceutical gatekeeping?

Rescheduling keeps Cannabis trapped inside the same failed framework that created prohibition in the first place. It preserves FDA and pharmaceutical industry control, limits access, criminalizes possession, and turns a plant into a patented commodity.

Descheduling does the opposite:

It removes Cannabis from the Controlled Substances Act

It expands research, not restricts it

It ends criminal penalties

It returns control to the people, not corporations

Let’s be honest about the motive.

The pharmaceutical industry wants to maintain control over Cannabis—isolating cannabinoids, patenting synthetics, and monetizing what nature already perfected. Had President Trump issued Executive Orders to deschedule Cannabis instead of rescheduling it, the pharmaceutical industry would have lost its regulatory chokehold on the plant.

This isn’t about science.

This isn’t about safety.

This isn’t about patients.

This is about profit over lives

This is about loss of personal freedom

Cannabis doesn’t need to be “managed” by the same institutions that demonized it for nearly a century.

It needs to be liberated.

#Deschedule #Decriminalize #FreeMarkets #ProfitOverLives #LossOfPersonalFreedom #CannabisBelongsToThePeople

H Marty Schelper is the Founder and President of both the Alabama Cannabis Coalition and Alabama Republicans Against Marijuana Prohibition. For more information, follow them on Facebook via the embedded links, or on the web at https://www.alabamacannabiscoalition.org/.

Opinions do not reflect the views and opinions of ALPolitics.com. ALPolitics.com makes no claims nor assumes any responsibility for the information and opinions expressed above.